These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11401943)

  • 1. Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling.
    Mankad S; d'Amato TA; Reichek N; McGregor WE; Lin J; Singh D; Rogers WJ; Kramer CM
    Circulation; 2001 Jun; 103(23):2845-50. PubMed ID: 11401943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.
    Kim YK; Mankad S; Kim SJ; Takagi G; Tamura T; Gerdes AM; Bishop SP; Kramer CM
    J Card Fail; 2003 Jun; 9(3):238-45. PubMed ID: 12815575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade improves adjacent regional sympathetic innervation during postinfarction remodeling.
    Kramer CM; Nicol PD; Rogers WJ; Seibel PS; Park CS; Reichek N
    Am J Physiol; 1999 Oct; 277(4):H1429-34. PubMed ID: 10516178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined angiotensin converting enzyme inhibition and angiotensin AT(1) receptor blockade up-regulates myocardial AT(2) receptors in remodeled myocardium post-infarction.
    Lee S; Kramer CM; Mankad S; Yoo SE; Sandberg K
    Cardiovasc Res; 2001 Jul; 51(1):131-9. PubMed ID: 11399255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
    J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.
    Hongo M; Sentianin EM; Tanaka N; Mao L; McKirnan MD; Clark RG; Won W; Chien KR; Ross J
    J Card Fail; 1998 Sep; 4(3):213-24. PubMed ID: 9754592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
    Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats.
    Zornoff LA; Paiva SA; Matsubara BB; Matsubara LS; Spadaro J
    J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):203-9. PubMed ID: 11150409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
    Youn TJ; Kim HS; Oh BH
    Basic Res Cardiol; 1999 Aug; 94(4):246-53. PubMed ID: 10505424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats.
    Jain M; Liao R; Ngoy S; Whittaker P; Apstein CS; Eberli FR
    Cardiovasc Res; 2000 Apr; 46(1):66-72. PubMed ID: 10727654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.